• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Activation of the complement system by pathogenic fungi.致病真菌对补体系统的激活。
Clin Microbiol Rev. 1996 Jan;9(1):34-46. doi: 10.1128/CMR.9.1.34.
2
Activation of the complement system by the capsule of Cryptococcus neoformans.新型隐球菌荚膜激活补体系统。
Curr Top Med Mycol. 1993;5:1-26.
3
Immune responses to fungal infections and therapeutic implications.针对真菌感染的免疫反应及其治疗意义。
Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):189-97. doi: 10.2174/1568008013341118.
4
Characteristics of immunity in fungal infections.真菌感染中的免疫特性。
Am J Vet Res. 1975 Apr;36(4 Pt 2):601-2.
5
An overview of macrophage-fungal interactions.巨噬细胞与真菌相互作用概述。
Mycopathologia. 1986 Feb;93(2):77-93. doi: 10.1007/BF00437738.
6
The immune response to fungal infections.对真菌感染的免疫反应。
Br J Haematol. 2005 Jun;129(5):569-82. doi: 10.1111/j.1365-2141.2005.05397.x.
7
Complement activation by pathogenic fungi.致病性真菌引起的补体激活。
Res Immunol. 1998 May-Jun;149(4-5):309-20; discussion 514-5. doi: 10.1016/s0923-2494(98)80755-4.
8
Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.白色念珠菌启动经典和替代补体途径的独特特征。
Infect Immun. 1996 Aug;64(8):3360-8. doi: 10.1128/iai.64.8.3360-3368.1996.
9
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.新型隐球菌荚膜启动替代补体途径激活的早期事件。
Infect Immun. 1991 Sep;59(9):3101-10. doi: 10.1128/iai.59.9.3101-3110.1991.
10
Fungal infections with a particular focus on the compromised host.特别关注免疫功能低下宿主的真菌感染。
Del Med J. 1982 Jan;54(1):11-9.

引用本文的文献

1
Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates.靶向念珠菌的单克隆抗体可破坏生物膜并抑制全球临床分离株的生长。
iScience. 2025 Apr 16;28(5):112459. doi: 10.1016/j.isci.2025.112459. eCollection 2025 May 16.
2
Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria.阵发性睡眠性血红蛋白尿症治疗中单克隆抗体的安全性概况及后续药物研发。
Medicina (Kaunas). 2024 Feb 24;60(3):379. doi: 10.3390/medicina60030379.
3
Diverse Functions of C4b-Binding Protein in Health and Disease.C4b 结合蛋白在健康和疾病中的多种功能。
J Immunol. 2023 Nov 15;211(10):1443-1449. doi: 10.4049/jimmunol.2300333.
4
Protective role of host complement system in infection.宿主补体系统在感染中的保护作用。
Front Immunol. 2022 Sep 23;13:978152. doi: 10.3389/fimmu.2022.978152. eCollection 2022.
5
Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages.全基因组 CRISPR 筛选揭示 C3aR 信号对巨噬细胞快速捕获真菌至关重要。
PLoS Pathog. 2022 Sep 29;18(9):e1010237. doi: 10.1371/journal.ppat.1010237. eCollection 2022 Sep.
6
Biological and Clinical Attributes of , a Causative Agent of Sporotrichosis.申克孢子丝菌的生物学和临床特征,孢子丝菌病的病原体
Infect Drug Resist. 2022 Apr 22;15:2067-2090. doi: 10.2147/IDR.S362099. eCollection 2022.
7
Host-Specific Serum Factors Control the Development and Survival of .宿主特异性血清因子控制 的发育和存活。
Front Immunol. 2021 Apr 23;12:635622. doi: 10.3389/fimmu.2021.635622. eCollection 2021.
8
The amphibian complement system and chytridiomycosis.两栖动物补体系统与壶菌病。
J Exp Zool A Ecol Integr Physiol. 2020 Dec;333(10):706-719. doi: 10.1002/jez.2419. Epub 2020 Oct 13.
9
and Complement: New Aspects in an Old Battle.和补体:旧战场的新视角。
Front Immunol. 2020 Jul 14;11:1471. doi: 10.3389/fimmu.2020.01471. eCollection 2020.
10
Mechanisms of Pathogenic Species to Evade the Host Complement Attack.致病物种逃避宿主补体攻击的机制。
Front Cell Infect Microbiol. 2020 Mar 12;10:94. doi: 10.3389/fcimb.2020.00094. eCollection 2020.

本文引用的文献

1
DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.抗原MUB1的分布、遗传特性及其与溶血补体的关系
J Exp Med. 1964 Nov 1;120(5):897-924. doi: 10.1084/jem.120.5.897.
2
Activity of mouse complement.小鼠补体的活性
J Immunol. 1962 Dec;89:861-7.
3
Natural host resistance to infection with Cryptococcus neoformans. I. The effect of the properdin system on the experimental disease.宿主对新型隐球菌感染的天然抵抗力。I. 备解素系统对实验性疾病的影响。
J Infect Dis. 1961 Sep-Oct;109:147-53. doi: 10.1093/infdis/109.2.147.
4
On the composition of zymosan.论酵母聚糖的组成
Science. 1958 Apr 4;127(3301):756-7. doi: 10.1126/science.127.3301.756-a.
5
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.备解素系统与免疫。I. 一种新的血清蛋白——备解素的证实、分离及其在免疫现象中的作用。
Science. 1954 Aug 20;120(3112):279-85. doi: 10.1126/science.120.3112.279.
6
Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.菌株变异、血清型及结构修饰对C3激活及与新型隐球菌结合动力学的影响。
Infect Immun. 1993 Jul;61(7):2966-72. doi: 10.1128/iai.61.7.2966-2972.1993.
7
Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.当C3b与新型隐球菌荚膜结合时,C3b加速降解为iC3b。
Infect Immun. 1993 Oct;61(10):4360-6. doi: 10.1128/iai.61.10.4360-4366.1993.
8
Complement binding to Aspergillus conidia correlates with pathogenicity.
J Lab Clin Med. 1993 Jul;122(1):27-35.
9
Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall.人血清中与新型隐球菌细胞壁反应的普遍存在抗体的发生情况、特异性及功能。
Infect Immun. 1994 Jan;62(1):215-20. doi: 10.1128/iai.62.1.215-220.1994.
10
Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans.C5和中性粒细胞在循环新型隐球菌肺血管内清除中的作用。
Am J Respir Cell Mol Biol. 1993 Dec;9(6):617-27. doi: 10.1165/ajrcmb/9.6.617.

致病真菌对补体系统的激活。

Activation of the complement system by pathogenic fungi.

作者信息

Kozel T R

机构信息

Department of Microbiology and Cell and Molecular Biology Program, University of Nevada, Reno 89557, USA.

出版信息

Clin Microbiol Rev. 1996 Jan;9(1):34-46. doi: 10.1128/CMR.9.1.34.

DOI:10.1128/CMR.9.1.34
PMID:8665475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172880/
Abstract

Fungi have been studied as prototype activators of the complement cascade since the early 1900s. More recently, attention has focused on the role of the complement system in the pathogenesis of fungal infections. The interactions of Cryptococcus neoformans and Candida albicans with the complement system are the most widely characterized; however, all pathogenic fungi examined to date have the ability to initiate the complement cascade. The molecular mechanisms for initiation and regulation of the complement cascade differ from one fungus to another, most likely reflecting differences in the structure of the outer layers of the cell wall. The molecular bases for such differences remain to be identified. Studies of mycoses in experimental animals with induced or congenital deficiencies in the complement system demonstrate that complement is an important innate system for control of fungal infection. Contributions to host resistance include opsonization and generation of inflammatory mediators. Inflammation induced by chemotactic products of the complement system may contribute to the pathogenesis of some fungal infections.

摘要

自20世纪初以来,真菌一直被作为补体级联反应的原型激活剂进行研究。最近,人们的注意力集中在补体系统在真菌感染发病机制中的作用上。新型隐球菌和白色念珠菌与补体系统的相互作用得到了最广泛的描述;然而,迄今为止所检测的所有致病真菌都有启动补体级联反应的能力。补体级联反应的启动和调节的分子机制因真菌而异,很可能反映了细胞壁外层结构的差异。这种差异的分子基础仍有待确定。对补体系统诱导性或先天性缺陷的实验动物进行的真菌病研究表明,补体是控制真菌感染的重要先天性系统。对宿主抵抗力的贡献包括调理作用和炎症介质的产生。补体系统趋化产物诱导的炎症可能有助于某些真菌感染的发病机制。